Abstract

Generally, automatic diagnosis of the presence of metastases in lymph nodes has therapeutic implications for breast cancer patients. Detection and classification of breast cancer metastases have high clinical relevance, especially in whole-slide images of histological lymph node sections. Fast early detection leads to huge improvement of patient’s survival rate. However, currently pathologists mainly detect the metastases with microscopic assessments. This diagnosis procedure is extremely laborious and prone to inevitable missed diagnoses. Therefore, automated, accurate patient-level classification would hold great promise to reduce the pathologist’s workload while also reduce the subjectivity of diagnosis. In this paper, we provide a novel deep regional metastases segmentation (DRMS) framework for the patient-level lymph node status classification. First, a deep segmentation network (DSNet) is proposed to detect the regional metastases in patch-level. Then, we adopt the density-based spatial clustering of applications with noise (DBSCAN) to predict the whole metastases from individual slides. Finally, we determine patient-level pN-stages by aggregating each individual slide-level prediction. In combination with the above techniques, the framework can make better use of the multi-grained information in histological lymph node section of whole-slice images. Experiments on large-scale clinical datasets (e.g., CAMELYON17) demonstrate that our method delivers advanced performance and provides consistent and accurate metastasis detection in clinical trials.

Highlights

  • Breast cancer is the most frequent cancer among women worldwide

  • We propose a deep regional metastases segmentation (DRMS) framework to predict pN-stage scores from patient’s whole slide histopathology images

  • Following the work in [28], we introduce the density-based spatial clustering of applications with noise (DBSCAN) algorithm to group together small metastases areas which were in close proximity

Read more

Summary

Introduction

Breast cancer is the most frequent cancer among women worldwide. According to the statistics from International Cancer Research Center (ICRC) of the World Health Organization (WHO), breast cancer impacts 2.1 million each year, and causes the greatest number of cancer-related deaths among women. In 2018, it is estimated that 627,000 women died from breast cancer - that is approximately 15% of all cancer deaths among women. The incidence rates vary widely, and the age-standardized incidence rate is as high as 99.4 per 100,000 in North America. The incidence rates in Eastern Europe, Southern America, Southern Africa, and Western Asia are slightly lower, they are increasing at the same time. The improvement of survival rates can be mainly achieved through early detection and diagnosis, which require a large proportion of women to seek medical treatments, appropriate diagnosis, and treatment facilities

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call